Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

MicroVision Announces Second Quarter 2023 Results


REDMOND, WA / ACCESSWIRE / August 8, 2023 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced its second quarter 2023 results.

 

"We are pleased with our forward momentum over the quarter and the uptick in inbound inquiries during the first half of 2023. Our deepening engagement with automotive OEMs includes opportunities for high-volume passenger vehicle programs as well as commercial vehicle programs seeking unique solutions. Our product offering gives us an array of strategic inroads as potential customers find our products compelling, inviting opportunities in automotive and industrial markets and allowing us to broaden our work with OEMs," said Sumit Sharma, MicroVision's Chief Executive Officer. "During the second quarter, we also strengthened our balance sheet, demonstrating to OEMs and other prospective customers and partners our financial strength and ability to scale multiple projects. While the challenging macro-economic environment caused headwinds that led some non-automotive customers to push out delivery requirements, we remain on track to delivering our 2023 development milestones."

 

"This quarter we continued to deliver technological progress, in particular demonstrating our sensor fusion software operating at speeds as high as 130 km/h," continued Sharma. "We made progress in the first half of this year, driven in part by the integration of products, technologies, and teams acquired from Ibeo Automotive earlier this year and we remain enthusiastic about MicroVision's future."

 

Key Financial Highlights for Q2 2023

 

-          Revenue for the second quarter of 2023 was $0.3 million, flat as compared to the second quarter of 2022. The revenue in the second quarter was primarily connected to the Ibeo acquisition and includes the sale of lidar hardware and related software to various customers.

-          Net loss for the second quarter of 2023 was $20.6 million, or $0.12 per share, which includes $3.0 million of a one-time gain included in other income due to early lease termination incentive offset by a $3.9 million share-based compensation expense, compared to a net loss for the second quarter of 2022 of $13.6 million, or $0.08 per share, which includes $4.1 million of non-cash, share-based compensation expense.

-          Adjusted Gross Profit for the second quarter of 2023 was $0.0 million, compared to $0.3 million for the second quarter of 2022.

-          Adjusted EBITDA for the second quarter of 2023 was a $15.2 million loss, compared to a $9.2 million loss for the second quarter of 2022.

-          Cash used in operations in the second quarter of 2023 was $16.6 million, compared to cash used in operations in the second quarter of 2022 of $9.7 million. This year-over-year increase was primarily driven by the increased operating expenses driven by the acquisition in January 2023.

-          The Company ended the second quarter of 2023 with $93.9 million in cash and cash equivalents including investment securities, compared to $82.7 million at December 31, 2022.

 

Conference Call and Webcast: Q2 2023 Results

 

MicroVision will host a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session at 2:00 PM PT/5:00 PM ET on Tuesday, August 8, 2023 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on August 8, 2023.

 

The live webcast and slide presentation can be accessed on the Company's Investor Relations website under the Events tab at https://ir.microvision.com/events . The webcast will be archived on the website for future viewing.

 

About MicroVision

 

With over 350 employees and global presence in Redmond, Detroit, Hamburg, and Nuremberg, MicroVision is a pioneering company in MEMS-based laser beam scanning technology that integrates MEMS, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. The Company's integrated approach uses its proprietary technology to provide automotive lidar sensors and solutions for advanced driver-assistance systems (ADAS) and for non-automotive applications including industrial, smart infrastructure and robotics. The Company has been leveraging its experience building augmented reality micro-display engines, interactive display modules, and consumer lidar modules.

 

For more information, visit the Company's website at www.microvision.com , on Facebook at www.facebook.com/microvisioninc , and LinkedIn at https://www.linkedin.com/company/microvision/ .

 

MicroVision, MAVIN, MOSAIK, and MOVIA are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

 

Non-GAAP information

 

To supplement MicroVision's condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measure "adjusted EBITDA" and "adjusted Gross Profit." Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; and share-based compensation. Adjusted Gross Profit is calculated as GAAP gross Profit before stock-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

 

MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision's past financial reports, and facilitates comparisons with other companies in the Company's industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses this non-GAAP measure when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company's operating results and facilitates comparisons of the Company's core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision's operating performance and the valuation of the Company.

 

Adjusted EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision's business as determined in accordance with GAAP. The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent. The Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted EBITDA.

 

Similarly for Adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross Profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out stock-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

 

Forward-Looking Statements

 

Certain statements contained in this release, including the Company's plans regarding benefits of the acquisition, market position, product portfolio, product capabilities, and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

 

Investor Relations Contact

 

Jeff Christensen

Darrow Associates Investor Relations

[email protected]

 

Media Contact

 

Robyn Komachi

[email protected]

 

MicroVision, Inc.

Consolidated Balance Sheet

(In thousands)

(Unaudited)

 

 

June 30,

 

 

December 31,

 

 

2023

 

 

2022

 

 

 

 

 

 

Assets

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash and cash equivalents

 

$

62,308

 

 

$

20,536

Investment securities, available-for-sale

 

 

31,565

 

 

 

62,173

Restricted cash, current

 

 

3,263

 

 

 

-

Accounts receivable, net

 

 

821

 

 

 

-

Inventory

 

 

2,933

 

 

 

1,861

Advance to IBEO

 

 

-

 

 

 

4,132

Deferred tax, current

 

 

53

 

 

 

-

Other current assets

 

 

2,332

 

 

 

2,306

Total current assets

 

 

103,275

 

 

 

91,008

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

9,949

 

 

 

6,830

Operating lease right-of-use asset

 

 

14,422

 

 

 

14,579

Restricted cash

 

 

961

 

 

 

1,418

Intangible assets, net

 

 

18,321

 

 

 

75

Non-current deferred tax assets

 

 

392

 

 

 

-

Other assets

 

 

1,335

 

 

 

1,086

Total assets

 

$

148,655

 

 

$

114,996

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Shareholders' Equity

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

Accounts payable

 

$

1,890

 

 

$

2,061

Accrued liabilities

 

 

6,595

 

 

 

2,058

Accrued liability for Ibeo business combination

 

 

6,191

 

 

 

-

Contract liabilities

 

 

5,729

 

 

 

4,601

Current portion of operating lease liability

 

 

2,285

 

 

 

1,846

Current portion of finance lease obligations

 

 

8

 

 

 

21

Other current liabilities

 

 

-

 

 

 

839

Total current liabilities

 

 

22,698

 

 

 

11,426

 

 

 

 

 

 

 

 

Operating lease liability, net of current portion

 

 

13,371

 

 

 

13,829

Other long-term liabilities

 

 

81

 

 

 

-

Total liabilities

 

 

36,150

 

 

 

25,255

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' Equity

 

 

 

 

 

 

 

Common stock at par value

 

 

188

 

 

 

171

Additional paid-in capital

 

 

835,410

 

 

 

772,221

Subscriptions receivable

 

 

(925)

 

 

 

-

Accumulated other comprehensive loss

 

 

(8)

 

 

 

(127)

Accumulated deficit

 

 

(722,160)

 

 

 

(682,524)

Total shareholders' equity

 

 

112,505

 

 

 

89,741

Total liabilities and shareholders' equity

 

$

148,655

 

 

$

114,996

 

 

 

 

 

 

 

 

MicroVision, Inc.

Consolidated Statement of Operations

(In thousands, except earnings per share data)

(Unaudited)

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

329

 

 

$

314

 

 

$

1,111

 

 

$

664

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

701

 

 

 

18

 

 

 

1,245

 

 

 

22

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

(372)

 

 

 

296

 

 

 

(134)

 

 

 

642

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expense

 

 

13,851

 

 

 

7,700

 

 

 

26,543

 

 

 

15,293

Sales, marketing, general and administrative expense

 

 

9,692

 

 

 

6,265

 

 

 

18,429

 

 

 

12,142

Gain on disposal of fixed assets

 

 

(15)

 

 

 

-

 

 

 

(15)

 

 

 

-

Total operating expenses

 

 

23,528

 

 

 

13,965

 

 

 

44,957

 

 

 

27,435

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(23,900)

 

 

 

(13,669)

 

 

 

(45,091)

 

 

 

(26,793)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bargain purchase gain

 

 

-

 

 

 

-

 

 

 

1,706

 

 

 

-

Other income, net

 

 

3,570

 

 

 

72

 

 

 

4,209

 

 

 

28

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss before taxes

 

$

(20,330)

 

 

$

(13,597)

 

 

$

(39,176)

 

 

$

(26,765)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(279)

 

 

 

-

 

 

 

(460)

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(20,609)

 

 

$

(13,597)

 

 

$

(39,636)

 

 

$

(26,765)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share - basic and diluted

 

$

(0.12)

 

 

$

(0.08)

 

 

$

(0.23)

 

 

$

(0.16)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding - basic and diluted

 

 

177,302

 

 

 

165,238

 

 

 

176,009

 

 

 

164,902

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MicroVision, Inc.

Consolidated Statement of Cash Flows

(In thousands)

(Unaudited)

 

 

Six months ended June 30,

 

 

2023

 

 

2022

 

 

 

 

 

 

Cash flows from operating activities

 

 

 

 

 

Net loss

 

$

(39,636)

 

 

$

(26,765)

Adjustments to reconcile net loss to net cash used in operations:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

4,151

 

 

 

901

Bargain purchase gain

 

 

(1,706)

 

 

 

-

(Gain)/Loss on disposal of fixed assets

 

 

(15)

 

 

 

-

Impairment of property and equipment

 

 

12

 

 

 

60

Inventory write-downs

 

 

56

 

 

 

17

Share-based compensation expense

 

 

6,815

 

 

 

7,854

Net accretion of premium on short-term investments

 

 

(695)

 

 

 

269

Non-cash interest expense

 

 

-

 

 

 

9

Change in

 

 

 

 

 

 

 

Accounts receivable

 

 

(821)

 

 

 

-

Contract assets

 

 

-

 

 

 

-

Inventory

 

 

69

 

 

 

(70)

Other current and non-current assets

 

 

(31)

 

 

 

1,213

Accounts payable

 

 

246

 

 

 

(1,874)

Accrued liabilities

 

 

4,138

 

 

 

246

Contract liabilities and other current liabilities

 

 

(1,692)

 

 

 

(1,845)

Operating lease liabilities

 

 

(1,096)

 

 

 

(619)

Other long-term liabilities

 

 

81

 

 

 

-

Net cash used in operating activities

 

 

(30,124)

 

 

 

(20,604)

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

Sales of investment securities

 

 

48,700

 

 

 

14,500

Purchases of investment securities

 

 

(17,302)

 

 

 

(38,134)

Cash paid for Ibeo business combination

 

 

(11,233)

 

 

 

-

Purchases of property and equipment

 

 

(1,484)

 

 

 

(1,128)

Net cash provided by (used in) investing activities

 

 

18,681

 

 

 

(24,762)

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

Principal payments under finance leases

 

 

(13)

 

 

 

(15)

Principal payments under long-term debt

 

 

-

 

 

 

(392)

Proceeds from stock option exercises

 

 

168

 

 

 

416

Net proceeds from issuance of common stock

 

 

55,866

 

 

 

-

Net cash provided by financing activities

 

 

56,021

 

 

 

9

 

 

 

 

 

 

 

 

Change in cash, cash equivalents, and restricted cash

 

 

44,578

 

 

 

(45,357)

Cash, cash equivalents and restricted cash at beginning of period

 

 

21,954

 

 

 

83,739

Cash, cash equivalents and restricted cash at end of period

 

$

66,532

 

 

$

38,382

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of June 30, 2023 and December 31, 2022:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30,

 

 

 

December 31,

 

 

 

2023

 

 

 

2022

Cash and cash equivalents

 

$

62,308

 

 

$

20,536

Restricted cash

 

 

4,224

 

 

 

1,418

Cash, cash equivalents and restricted cash

 

 

66,532

 

 

 

21,954

MicroVision, Inc.

Reconciliation of GAAP to Non-GAAP Measures

(In thousands, except earnings per share data)

(Unaudited)

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Non-GAAP Gross Profit:

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

$

(372)

 

 

$

296

 

 

$

(134)

 

 

$

642

Share-based compensation expense

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

Amortization of acquired intangibles

 

 

387

 

 

 

-

 

 

 

642

 

 

 

-

Non-GAAP Gross Profit

 

$

15

 

 

$

296

 

 

$

508

 

 

$

642

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of GAAP Net Loss to Non-GAAP Measure:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Net loss

 

$

(20,609)

 

 

$

(13,597)

 

 

$

(39,636)

 

 

$

(26,765)

Add Interest (net)

 

 

(446)

 

 

 

(107)

 

 

 

(945)

 

 

 

(138)

Add Income taxes

 

 

345

 

 

 

-

 

 

 

526

 

 

 

-

Add Depreciation amortization

 

 

1,627

 

 

 

418

 

 

 

4,151

 

 

 

901

Add Bargain purchase gain

 

 

-

 

 

 

-

 

 

 

(1,706)

 

 

 

-

Add Share-based compensation expense

 

 

3,866

 

 

 

4,120

 

 

 

6,815

 

 

 

7,854

Adjusted EBITDA

 

$

(15,217)

 

 

$

(9,166)

 

 

$

(30,795)

 

 

$

(18,148)

SOURCE: MicroVision, Inc.

 

MicroVision Inc Aktie

1,06 €
2,26 %
Ein signifikanter Gewinn für MicroVision Inc heute, um 2,26 %.
Die Community ist bei MicroVision Inc noch unentschieden: Nur wenige Einschätzungen.
Das Kursziel von 4 €, festgelegt von der Community für MicroVision Inc, zeigt ein Potenzial von 276.15%, was einer Verdopplung des aktuellen Kurses entspricht.
Like: 0
Teilen

Kommentare